AM-855
![]()  | |
| Systematic (IUPAC) name | |
|---|---|
| 
 (4aR,12bR)-8-hexyl-2,5,5-trimethyl-1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol  | |
| Identifiers | |
| CAS Number | 249888-50-4 | 
| PubChem | CID 10091328 | 
| ChemSpider | 
8266865  | 
| ChEMBL | 
CHEMBL303479  | 
| Chemical data | |
| Formula | C26H38O2 | 
| Molar mass | 382.577 g/mol | 
  | |
  | |
| (verify) | |
AM-855 (part of the AM cannabinoid series) is an analgesic drug which is a cannabinoid agonist. It is a derivative of Δ8Tetrahydrocannabinol with a conformationally restricted side chain which has been bound into a fourth ring fused to the aromatic A-ring of the cannabinoid skeleton. AM-855 is an agonist at both CB1 and CB2 with moderate selectivity for CB1, with a Ki of 22.3nM at CB1 and 58.6nM at CB2.[1]
References
- ↑ Khanolkara, Atmaram D.; Lua, Dai; Fana, Pusheng; Tiana, Xiaoyu; Makriyannis, Alexandros (August 1999). "Novel conformationally restricted tetracyclic analogs of Δ8-tetrahydrocannabinol". Bioorganic & Medicinal Chemistry Letters 9 (15): 2119–24. doi:10.1016/S0960-894X(99)00355-8. PMID 10465529.
 
This article is issued from Wikipedia - version of the Wednesday, February 17, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
